High Court to Review Myriad (MYGN) Patent on Genes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. BAC
2. JPM
3. IBM
4. PYPL
5. PNR
6. GS
7. KMTS
8. JNJ
9. GOOGL
10. PXED

Go back to High Court to Review Myriad (MYGN) Patent on Genes
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 6.04 --0 (-0%)
Previous Close $6.04    52 Week High $45.34 
Open $6.04    52 Week Low $15.92 
Day High $6.04    P/E 2.59 
Day Low $6.04    EPS $2.33 
Volume 38